Lung cancer screening with low-dose computed tomography—where do we go from here? Taking a look at the possibilities in our JNCI editorial academic.oup.com/jnci/article/d…

There's been a lot of misinformation about Laura's and my politics of late that I'd like to clarify. TLDR: we don't associate with either party but support individual politicians who work in good faith to improve lives. Most people involved in politics see the biggest divide as

The perfect Election Day home page. Twin “covering the bases”explanations for the possible outcomes, with an ad about moving to Mexico in the middle. Ty The New York Times

A wrote a little personal essay for @harvardeducation magazine about my “mid-life crisis master’s degree.” Thanks @eloehgse for an amazing experience and letting me share my journey!

My brilliant wife Bianca Turetsky explaining her rationale, and its reward, for pursuing a (mid-life crisis) master's degree. Lucky to witness it. Who knew they still assigned homework? gse.harvard.edu/ideas/ed-magaz…

Read the full editorial now at BMJ Oncology: bmjoncology.bmj.com/content/4/1/e0…

With the unfortunate news about 23andMe today, here is the profile I wrote of Anne Wojcicki in 2015 right after their encounter with the FDA. townandcountrymag.com/style/beauty-p…

With the unfortunate news about 23andMe today, here is my profile of Anne Wojcicki in 2015 for TOWN&COUNTRY right after the company's first encounter with the FDA. townandcountrymag.com/style/beauty-p…

A peek into Gardiner Harris book "No More Tears" in STAT. The piece focuses on JnJ's role in pushing EPO after data were definitive that it was harmful. The book marches out a laundry list of equally concerning actions by the company. It's harrowing. statnews.com/2025/04/03/ery…

Today's interview on FreshAir: npr.org/2025/04/10/nx-…

Great piece from Katelyn Jetelina and the importance of listening to the other side at this difficult moment in public health. Went in with a plan to have her listen to talk ratio at 3:1. This is how to improve health with information. yourlocalepidemiologist.substack.com/p/a-meeting-wi…

“Moral Ambition” by Rutger Bregman arrives today in the US! That man has the best handwriting I’ve ever seen. 😀 Congrats Rutger the world definitely needs more moral ambition. rutgerbregman.com/books/moral-am…

If we are talking MFN for drug pricing, ditch three false framings first. - Not 'price controls', changes prices offered and voluntarily accepted - Int'l price diff reflect price discrimination based on WTP, not US subsidy - Int'l price diff are real and large, net of rebates

Somehow this headline feels like a Harvard is trolling in a very Harvard way npr.org/2025/05/15/nx-…

Firearm Laws & Pediatric Mortality in US One of our more imp papers; great team effort led by Jeremy Faust MD MS (ER physician) 'permissive firearm laws contributed to thousands of excess firearm deaths among children in states w/permissive policies' Yale School of Medicine Harvard Medical School jamanetwork.com/journals/jamap…

Thinking about my dad, Fritz Bach, today. Stateless in 1948, disembarked the Marine Tiger at New York harbor, welcomed to this country of unlimited potential. Every time we were in Times Square he would tell me about the night he saw it for the first time with his brother Bert.

Even the NYT seems to have forgotten that debt is a function of both revenue and spending. No mention here of increasing taxes as part of the solution as if it isn't a lever. nytimes.com/2025/06/19/bus…

Good summary of key issues. Cancer drugs cost more than ever, but some blockbuster treatments have never proven they keep patients alive longer bloomberg.com/graphics/2025-… via @bbgvisualdata

Sarepta Therapeutics has refused the FDA’s request that it pull gene therapy from the market following patient deaths statnews.com/2025/07/18/sar…